Literature DB >> 28710748

Longitudinal Changes in White Matter Fractional Anisotropy in Adult-Onset Niemann-Pick Disease Type C Patients Treated with Miglustat.

Elizabeth A Bowman1, Dennis Velakoulis2,3, Patricia Desmond4,5, Mark Walterfang6,7,8.   

Abstract

Niemann-Pick disease type C (NPC) is a rare neurometabolic disorder resulting in impaired intracellular lipid trafficking. The only disease-modifying treatment currently available is miglustat, an iminosugar that inhibits the accumulation of lipid metabolites in neurons and other cells. This longitudinal diffusion tensor imaging (DTI) study examined how the rate of white matter change differed between treated and non-treated adult-onset NPC patient groups. Nine adult-onset NPC patients (seven undergoing treatment with miglustat, two not treated) underwent DTI neuroimaging. Rates of change in white matter structure as indexed by Tract-Based Spatial Statistics (TBSS) of fractional anisotropy were compared between treated and untreated patients. Treated patients were found to have a significantly slower rate of white matter change in the corticospinal tracts, the thalamic radiation and the inferior longitudinal fasciculus. This is further evidence that miglustat treatment may have a protective effect on white matter structure in the adult-onset form of the disease.

Entities:  

Keywords:  Diffusion tensor imaging; Fractional anisotropy; Miglustat; Niemann-Pick type C; White matter

Year:  2017        PMID: 28710748      PMCID: PMC5953894          DOI: 10.1007/8904_2017_42

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  21 in total

1.  GABAergic neuroaxonal dystrophy and other cytopathological alterations in feline Niemann-Pick disease type C.

Authors:  P A March; M A Thrall; D E Brown; T W Mitchell; A C Lowenthal; S U Walkley
Journal:  Acta Neuropathol       Date:  1997-08       Impact factor: 17.088

Review 2.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

3.  The neuropsychiatry of Niemann-Pick type C disease in adulthood.

Authors:  Mark Walterfang; Michael Fietz; Michael Fahey; Danny Sullivan; Pamela Leane; Dan I Lubman; Dennis Velakoulis
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2006       Impact factor: 2.198

4.  Eye movement and diffusion tensor imaging analysis of treatment effects in a Niemann-Pick Type C patient.

Authors:  Michael Scheel; Mathias Abegg; Linda J Lanyon; Andre Mattman; Jason J Barton
Journal:  Mol Genet Metab       Date:  2009-10-30       Impact factor: 4.797

5.  Neurodegeneration in the Niemann-Pick C mouse: glial involvement.

Authors:  D C German; C-L Liang; T Song; U Yazdani; C Xie; J M Dietschy
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

6.  White and gray matter alterations in adults with Niemann-Pick disease type C: a cross-sectional study.

Authors:  M Walterfang; M Fahey; P Desmond; A Wood; M L Seal; C Steward; C Adamson; C Kokkinos; M Fietz; D Velakoulis
Journal:  Neurology       Date:  2010-05-19       Impact factor: 9.910

7.  Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations.

Authors:  M Zervas; K Dobrenis; S U Walkley
Journal:  J Neuropathol Exp Neurol       Date:  2001-01       Impact factor: 3.685

8.  Miglustat improves purkinje cell survival and alters microglial phenotype in feline Niemann-Pick disease type C.

Authors:  Veronika M Stein; Alexandra Crooks; Wenge Ding; Maria Prociuk; Patricia O'Donnell; Caroline Bryan; Tracey Sikora; Jasper Dingemanse; Marie T Vanier; Steven U Walkley; Charles H Vite
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

9.  Size and shape of the corpus callosum in adult Niemann-Pick type C reflects state and trait illness variables.

Authors:  M Walterfang; M Fahey; L Abel; M Fietz; A Wood; E Bowman; D Reutens; D Velakoulis
Journal:  AJNR Am J Neuroradiol       Date:  2011-05-19       Impact factor: 3.825

10.  Normalisation of brain spectroscopy findings in Niemann-Pick disease type C patients treated with miglustat.

Authors:  Frédéric Sedel; Brigitte Chabrol; Bertrand Audoin; Elsa Kaphan; Christine Tranchant; Tomasz Burzykowski; Ayman Tourbah; Marie T Vanier; Damien Galanaud
Journal:  J Neurol       Date:  2016-03-16       Impact factor: 4.849

View more
  4 in total

Review 1.  Psychiatric and Cognitive Symptoms Associated with Niemann-Pick Type C Disease: Neurobiology and Management.

Authors:  Thomas Rego; Sarah Farrand; Anita M Y Goh; Dhamidhu Eratne; Wendy Kelso; Simone Mangelsdorf; Dennis Velakoulis; Mark Walterfang
Journal:  CNS Drugs       Date:  2019-02       Impact factor: 5.749

2.  Cognitive impairment profile in adult patients with Niemann pick type C disease.

Authors:  Camille Heitz; Stéphane Epelbaum; Yann Nadjar
Journal:  Orphanet J Rare Dis       Date:  2017-10-18       Impact factor: 4.123

Review 3.  Miglustat in Niemann-Pick disease type C patients: a review.

Authors:  Mercè Pineda; Mark Walterfang; Marc C Patterson
Journal:  Orphanet J Rare Dis       Date:  2018-08-15       Impact factor: 4.123

4.  Lysosomal diseases: Overview on current diagnosis and treatment.

Authors:  Fabiano de Oliveira Poswar; Filippo Vairo; Maira Burin; Kristiane Michelin-Tirelli; Ana Carolina Brusius-Facchin; Francyne Kubaski; Carolina Fischinger Moura de Souza; Guilherme Baldo; Roberto Giugliani
Journal:  Genet Mol Biol       Date:  2019-04-25       Impact factor: 1.771

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.